CORCEPT THERAPEUTICS INCORPORATED - MEDIAN PFS OF 7.2 MONTHS FOR LIFYORLI PLUS NAB-PACLITAXEL AND BEVACIZUMAB IN BELLA

Reuters · 2d ago

Please log in to view news